Applications of (S)-(+)-2-(Anilinomethyl)Pyrrolidine in Industrial Manufacturing

(S)-(+)-2-(Anilinomethyl)Pyrrolidine serves as a critical chiral intermediate across several advanced chemical manufacturing sectors. Our direct production supports strict downstream requirements in pharmaceutical synthesis, chiral ligand formulation, agrochemical active ingredient creation, and fine chemical research. Each application below reflects real-world use cases, precise compliance needs, validated process parameters, and common end products.

1. Active Pharmaceutical Ingredient (API) Synthesis: Chiral Drug Intermediates

Our material is valued by API manufacturers for asymmetric synthesis, specifically for enantioselective preparation of β-adrenergic blockers, antidepressants, and related drug candidates. It enters multi-step reaction sequences where high enantiopurity is mandatory, contributing to the stereochemical core of the final API. Advanced pharmaceutical plants engage it at gram-to-metric ton scale, adapting process conditions according to required regulatory filings and final dose forms.

Industry compliance standards

• ICH Q7A – Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
• US FDA 21 CFR Part 210/211 (cGMP for finished pharmaceuticals)
• European Pharmacopoeia (Ph. Eur., specific monographs for intermediates where applicable)
• Chinese Pharmacopoeia (ChP), for APIs supplied into China

Typical usage ratio

• 0.6–1.5 molar equivalents per target molecule, depending on reaction stoichiometry and target yield
• Adjust proportion based on route development data and impurity limits

Downstream process integration

• Charged as a key input during early-to-mid stage of multi-step chiral amine synthesis
• Undergoes catalytic coupling, reduction, or protection/deprotection and extraction
• Subject to in-process control by HPLC/GC for enantiomeric excess
• Any residuals or by-products are purged in subsequent purification or crystallization stages

Final product types

• Pharmaceutical active ingredients for cardiovascular therapy (e.g., selective β1-blockers)
• Chiral precursors for central nervous system agents (e.g., antidepressant intermediates)
• Investigational new drugs (INDs) developed under DMF filings
• High-purity building blocks for contract research organizations (CROs)

2. Chiral Ligand Manufacturing for Asymmetric Catalysis

Leading catalyst producers source this pyrrolidine derivative for chiral ligand synthesis in homogeneous catalysis. Small molecule ligands, often incorporating aniline and pyrrolidine frameworks, drive enantioselectivity in metal-catalyzed transformations such as asymmetric hydrogenation or cross-coupling. Batch and continuous manufacturing both exploit specific ratios to optimize metal complex stability and product yield in custom catalyst development.

Industry compliance standards

• ISO 9001:2015 Quality Management System in specialty chemical production
• REACH compliance for chemical safety within the European Union
• Responsible Care® certification for process safety and product stewardship
• Specialty chemical producer QC protocols (NMR, MS, chiral HPLC/GC analysis)

Typical usage ratio

• 0.8–1.2 molar equivalents, depending on coordination chemistry and ligand-metal complex design
• Adjusted during process development trials for catalyst efficiency testing

Downstream process integration

• Reacted with transition metal salts (e.g., Rh, Pd, Ru) in batch reactors
• Facilitates complexation with metal centers via direct amine coordination
• Ligands purified by crystallization, chromatography, then qualified for pilot or commercial use
• Stringent batch traceability maintained for catalytic activity certification

Final product types

• Enantioselective chiral catalysts for API synthesis
• Premium chiral ligands for contract research and fine chemical markets
• Homogeneous catalyst kits for process development laboratories
• Catalog specialty chemicals for catalyst manufacturers

3. Agrochemical Intermediate Production: Chiral Pesticide Precursors

Agrochemical formulators integrate this material to generate enantiomerically enriched intermediates crucial for high-performance pesticides and herbicides. The compound's chiral nature supports target-specific crop protection agents, where regulatory-driven selectivity and low non-target impact are required. Processing lines utilize it in scalable synthesis steps, with tight control over enantiomeric purity and batch reproducibility.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS) guidelines
• ISO 17025 certified Quality Control testing for raw material and intermediate purity
• National registration requirements (EPA, REACH) for agrochemical actives
• GLP (Good Laboratory Practice) for field trial intermediates

Typical usage ratio

• 0.5–1.0 molecular equivalents for main intermediate formation
• Adjusted for process impurity limits as per downstream registration data

Downstream process integration

• Undergoes cyclization or coupling reactions for active intermediate formation
• Blended with reactants in jacketed reactors with automation for exothermic control
• In-process analytics employed (qNMR, GC-MS, HPLC) to confirm stereochemical integrity
• Purified and transferred to final active synthesis or formulation

Final product types

• Chiral herbicide intermediates for maize, soybean, or rice protection
• Enantiopure insecticide precursor molecules
• Regulated plant protection actives incorporating chiral amine motifs
• Export-grade pesticide intermediates for multi-national agrochemical companies

4. Advanced Fine Chemicals and R&D Synthesis

Chemical R&D centers and fine chemicals manufacturers use this compound to develop specialized molecules for analytical standards, reagent kits, and high-value research building blocks. The product’s defined stereochemistry supports the construction of reference materials and custom synthons, particularly in route scouting and scale-up studies for new chemical entities in academia and industry.

Industry compliance standards

• ISO 9001:2015 for laboratory and pilot plant operations
• Analytical testing protocols (internal QC following SOPs for NMR, IR, mass spectrometry)
• Material Safety Data Sheet (MSDS) conformity for chemical supply
• Responsible management of controlled substances as required by local regulation

Typical usage ratio

• 1.0–2.0 equivalents in multi-step syntheses for research or analytical reference compound preparation
• Ratio varies by target molecular complexity and desired scale (mg-kg)

Downstream process integration

• Applied during key transformation steps in synthetic route development
• Processed with automated or manual purification (MPLC, prep HPLC, crystallization)
• Batch tested for chiral purity and structure confirmation before customer shipment
• Offered with full traceability and batch documentation for research compliance

Final product types

• Chiral reference standards for analytical laboratories
• Custom synthons for medicinal chemistry and lead optimization studies
• Research-scale intermediates for academic labs and industrial innovation
• Building blocks for specialty dye, optical, or sensor development